Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient (NCT02783209) | Clinical Trial Compass
TerminatedNot Applicable
Effect on the Vitreous of the Not Complicated Surgery of the Cataract to the Emmetropic Patient
Stopped: Major difficulties of patient inclusions
France30 participantsStarted 2014-12
Plain-language summary
This study evaluates the association between surgery of the cataract and posterior vitreous detachment, in the emmetropic patient, by comparing eyes operated with eyes not operated in the same group of patients
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult emmetropic patient
* Without complete posterior vitreus detachment in both eyes before having surgery.
Exclusion Criteria:
* Diabetic retinopathy
* Ophthalmological treatment in progress
* History of ophthalmological surgery
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial was terminated before it finished — can you tell me why it was stopped early, and what that means for the reliability of any findings about whether cataract surgery affects the vitreous?
2The study was looking at whether routine cataract surgery in patients with normal vision (emmetropia) can trigger vitreous detachment — is this a real risk I should be aware of before my own cataract procedure?
3Since this trial has been terminated and is listed as 'Not Applicable' for phase, meaning it wasn't testing a new drug or device, what current evidence does my doctor rely on to assess vitreous detachment risk after cataract surgery?
4If vitreous detachment is a possible outcome of cataract surgery, what symptoms should I watch for after an operation, and how soon should I seek care if I notice them?
5Are there alternative monitoring approaches or surgical techniques my doctor uses to reduce the chance of vitreous changes after cataract surgery, given that this study didn't complete its research?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Occurence of vitreous detachment in the operated eye
Timeframe: 3 months after the cataract surgery
Trial details
NCT IDNCT02783209
SponsorFondation Ophtalmologique Adolphe de Rothschild